https://in.marketscreener.com/news/avacta-therapeutics-conditionally-raises-gbp10-million-via-share-placing-subscription-ce7e51dbdc8afe23
Avacta Therapeutics Conditionally Raises GBP10 Million via Share Placing, Subscription |...
Mar 27, 2026 - Avacta Therapeutics conditionally raised 10 million pounds sterling in gross proceeds through a placing and subscription offer for new shares. The...
avacta therapeuticsraisesmillionviashare
https://avacta.com/peel-hunt-healthcare-life-sciences-podcast-with-christina-coughlin/
Peel Hunt Healthcare & Life Sciences Podcast with Christina Coughlin | Avacta Therapeutics
healthcare life sciencespeel hunt
https://avacta.com/category/investors/
Investors | Avacta Therapeutics
investorsavactatherapeutics
https://in.marketscreener.com/news/avacta-therapeutics-announces-first-patient-treated-in-phase-1-focus-01-trial-of-fap-exd-ce7e51dfdb8cf52c
Avacta Therapeutics Announces First Patient Treated In Phase 1 Focus-01 Trial Of FAP-Exd |...
Mar 31, 2026 - Avacta Therapeutics had announced that the first patient has been treated in the FOCUS-01 trial, the multicenter, open-label Phase 1 clinical trial of FAP-Exd...